Nitrofurantoin

  • PDF / 140,784 Bytes
  • 1 Pages / 595.245 x 841.846 pts (A4) Page_size
  • 60 Downloads / 160 Views

DOWNLOAD

REPORT


1

S

Pulmonary fibrosis in an elderly patient: case report An elderly patient [age and sex not stated] with recurrent urinary tract infections was receiving 18-month treatment with nitrofurantoin, and developed CT-confirmed pulmonary fibrosis [route, dosage, duration of treatment to reaction onset and outcome not stated]. This case was reported to the Danish Medicines Agency. Author comment: "The summary of product characteristics for the product [Nitrofurantoin] states that it may cause acute and chronic pulmonary changes". Danish Health and Medicines Authority. Risk of developing acute and chronic pulmonary changes in treatment with Nitrofurantoin. Danish Pharmacovigilance Update 3: 5, No. 5, 24 May 2012. Available from: URL: http:// 803075097 laegemiddelstyrelsen.dk - Denmark

0114-9954/10/1414-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Reactions 11 Aug 2012 No. 1414